Abstract
This research service provides an assessment of key component technology areas
within the omics space, and offers insights and recommendations for managing
the R&D portfolio effectively. Incorporated analysis includes a strategic
evaluation of R&D portfolio within this space using a multicriteria decision
making tool, an assessment of research orientation among key focus areas in
the industry, analysis of the challenging environment for R&D, and an overview
of emerging market needs. Finally, a discussion of future R&D trends and
insights on strategically managing the R&D pipeline is also included.
Table of Contents
1. Executive Summary
- Research Scope and Methodology
- Scope of the Research Service
- Methodology
- Research Overview An Introduction to Omics
- Classification of Omics-based Technology
- Application of Omics Across Industries and Academia
2. Strategic Assessment of the Industry Environment
- R&D Portfolio Analysis
- Research Portfolio
- R&D Budgetary Analysis
- Omics Technology Platforms--Diagnostics and Therapeutics
- Research Orientation Focus of Omics Platforms
- Omics-based Diagnostics for Cancer
- Omics-based Diagnostics for Neurological Disorders
- Omics-based Diagnostics for Cardiovascular Diseases
- Omics-based Diagnostics for Renal and Hepatic Diseases
- Omics-based Diagnostics for Infectious Diseases
- Environmental Analysis
- Factors Accelerating Technology Development
- Emerging Market Needs
- Key Technical Challenges
- Key Business Challenges
- Restraints for Technology Development
3. Strategic Evaluation of R&D Portfolio
- Technology Development Market Landscape Industry Best Practices and
Strategic Insights
- Assessment of Partnerships/Alliances
- Strategic Recommendations (AHP Analysis)
4. Patents; Contacts; and Appendix
- Key Patents and Appendix
- Contacts
- Contacts--Part 1
- Appendix A1: Analytical Hierarchy Process
- Contacts--Part 2
5. Decision Support Tables
- Critical Reference Tables
- Pharma Research and Development Expenditure (2006 To 2016)
- Percentage Pharma Research and Development Expenditure (2006 To 2016)
- Number of Biotech Companies (2006 To 2016)